CSIR-CDRI & ICMR will soon start Phase-III clinical trials for "Picroliv" for the treatment of Fatty Liver.
CSIR-CDRI's Phytopharmaceutical product, "Picroliv" got the nod for Phase-III clinical trial for the treatment of fatty liver disease.@ICMRDELHI pic.twitter.com/tds5QkMzga— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) February 25, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


